Analyst ratings and price targets can significantly influence the market's perception of a stock. In this case, the reiteration of a 'Buy' rating and a maintained price target of $5 by HC Wainwright & Co. for Outlook Therapeutics could lead to increased investor confidence and potentially positive price movement in the short term.